Eitan Medical
A Single Solution for Every Infusion Need

With COVID-19 infections still on the rise, it is imperative that the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies is also well-managed. Driven by a rising geriatric population, improving patient compliance, beneficial reimbursement policies, surging research, and FDA approvals is bolstering the growth of the market over the next few years. Furthermore, owing to the COVID-19 pandemic, the market is expected to reach $50.9 billion in 2025 at a CAGR of 4.5 percent. However, strict and ever-changing regulatory requirements for approval of drug delivery devices and lack of skilled and trained professionals to administer drugs are restraining the growth of the global drug delivery devices market. In addition, developing drug delivery systems is a lengthy, complex, and costly process, entrenched with a high degree of uncertainty that it will actually succeed. As animal models often cannot recapitulate an entire disorder or disease, greater emphasis on human data might lead to improved target identification and validation. That said, with the right approaches, systems, tools, and effective collaboration across multiple functions and organisations can bring the benefits of robust and efficient drug delivery devices to patients. This is where one company, Eitan Medical, is making waves in the market by creating a world-class patient experience through easy-to-use, reliable drug delivery, and infusion solutions. The company is delivering connected, intuitive infusion solutions designed to improve patients' and clinicians' quality of life across the continuum of care, including hospital, ambulatory care, and home care solutions.

"We are re-imagining drug delivery with rapid innovation that puts patients at the center of care, making infusion easier and safer than ever before," states Igal Shany, CEO of Eitan Group.

We are re-imagining drug delivery with rapid innovation that puts patients at the center of care, making infusion easier and safer than ever before

Eitan Medical offers tailored solutions for a variety of infusion needs, including hospitalization, pain, nutrition, pre-hospital transpiration, ambulatory, and home infusion, in a single pump based on patented flow control technology and with build-in safety mechanisms for maximum safety. The company's Sapphire family of infusion pumps solutions are designed with patient safety as the starting point for infusion across the continuum of care, from the hospital to the home. The Sapphire family solutions are built with an intuitive touch screen interface, a minimal footprint for consistently high performance. By utilizing its patented and advanced technologies, Eitan Medical aims to enhance patient safety through the quick setup and intuitive workflows to help medical-workers improve response time for multiple programming modes to meet every patient's needs.

The current drug delivery development pipeline is multifaceted and complex. An opportunity to improve and accelerate drug development through emerging new tools and technologies, novel methodological approaches and infrastructural changes is essential to providing the safest and most reliable treatments for patients. For over a decade, Eitan Medical and its global partners have strived to provide safe, intuitive, and flexible infusion solutions that meet evolving drug delivery needs. The company has designed a range of accessories and dedicated sets for use in both home care and hospital settings by ensuring an improved patient self-administration experience by enabling new therapy options. Eitan Medical's technological flexibility, coupled with its total market approach, strikes the perfect balance between patient's and pharma companies' needs. In addition, the company's innovative solutions are specifically designed to fit into the changing regulatory, industrial, and data privacy landscape. "Our commitment to delivering solutions that offer extreme ease of use make Sapphire products the solution of choice for infusion across the continuum of care, from the hospital to the home," - Igal Shany.